Generex Biotechnology Corporation Granted United States Patent In Connection With Its RapidMist(TM) Device

Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that it has been granted another United States patent. The patent entitled, “Cleaning Compounds for and Method of Cleaning Valves and Actuators of Metered Dose Dispensers Containing Pharmaceutical Compositions,” relates to the formulation and methodology for cleaning the Company’s proprietary RapidMist device which is designed to deliver pharmaceutical products, including Oral-lyn™, the Company’s proprietary oral insulin product, into the buccal cavity (the mouth) where it is absorbed into the bloodstream.